The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Clement Christopher G since 2005.
The trader's CIK number is 1218808.
At the time of the last reporting, Clement Christopher G was the President & CEO of Point Therapeutics Inc. (stock ticker symbol POTP).
Also see all insider trading activities at Point Therapeutics Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2013 | DARA | 14,000 | $9,982 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2009 | SVNT | 0 | $0 | 83,277 | $1,641,446 | 37,000 | $105,231 |
| 2007 | SVNT | 0 | $0 | 60,692 | $804,059 | 0 | $0 |
| 2006 | SVNT | 0 | $0 | 10,313 | $60,537 | 0 | $0 |
| 2005 | SVNT | 15,000 | $46,350 | 0 | $0 | 0 | $0 |
1. Point Therapeutics Inc (DARA)
2. Savient Pharmaceuticals Inc (SVNT)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2013-06-03 | DARA | Buy | 14,000 | .71 | 9,982 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2009-12-09 | SVNT | Sale | 200 | 4.81 | 961 |
| 2008-12-09 | SVNT | Sale | 9,225 | 4.79 | 44,187 |
| 2008-04-14 | SVNT | Sale | 7,570 | 19.06 | 144,299 |
| 2008-02-15 | SVNT | Sale | 11,112 | 20.00 | 222,240 |
| 2008-01-17 | SVNT | Option Ex | 5,000 | 2.97 | 14,850 |
| 2008-01-15 | SVNT | Sale | 5,000 | 21.36 | 106,795 |
| 2008-01-16 | SVNT | Option Ex | 5,000 | 2.97 | 14,850 |
| 2008-01-15 | SVNT | Option Ex | 5,000 | 2.88 | 14,375 |
| 2008-01-17 | SVNT | Sale | 5,000 | 20.29 | 101,450 |
| 2008-01-16 | SVNT | Sale | 5,000 | 21.24 | 106,199 |
| 2008-01-10 | SVNT | Option Ex | 5,000 | 2.78 | 13,899 |
| 2008-01-11 | SVNT | Option Ex | 5,000 | 2.78 | 13,899 |
| 2008-01-10 | SVNT | Sale | 5,000 | 22.42 | 112,100 |
| 2008-01-11 | SVNT | Sale | 5,000 | 22.00 | 109,995 |
| 2008-01-14 | SVNT | Option Ex | 5,000 | 2.78 | 13,899 |
| 2008-01-14 | SVNT | Sale | 5,000 | 21.64 | 108,200 |
| 2008-01-08 | SVNT | Option Ex | 2,000 | 2.78 | 5,560 |
| 2008-01-07 | SVNT | Sale | 5,000 | 23.00 | 115,000 |
| 2008-01-09 | SVNT | Option Ex | 5,000 | 2.78 | 13,899 |
| 2008-01-08 | SVNT | Sale | 5,170 | 23.15 | 119,690 |
| 2008-01-09 | SVNT | Sale | 5,000 | 21.88 | 109,410 |
| 2008-01-03 | SVNT | Sale | 5,000 | 24.23 | 121,160 |
| 2008-01-02 | SVNT | Sale | 5,000 | 23.95 | 119,760 |
| 2007-12-10 | SVNT | Sale | 11,229 | 15.26 | 171,354 |
| 2007-04-12 | SVNT | Sale | 7,608 | 12.00 | 91,296 |
| 2007-03-05 | SVNT | Sale | 34,231 | 12.59 | 430,968 |
| 2007-02-15 | SVNT | Sale | 7,624 | 14.49 | 110,441 |
| 2006-04-12 | SVNT | Sale | 10,313 | 5.87 | 60,537 |
| 2005-05-18 | SVNT | Buy | 15,000 | 3.09 | 46,350 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Clement Christopher G (President & CEO of Point Therapeutics Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.